InCarda Therapeutics
Newark, CA
InCarda Therapeutics, Inc. operates as a biotechnology company. The Company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics focuses on the development and commercialization of therapies for acute cardiovascular conditions.
incardatherapeutics.comCompany Details
Founded
- 2009
Employees
- Between 10 - 100 employees
Raised
- $129,376,976
Headquarters Location
- Newark, CA
Public
- No
Acquired
- No
CEO
Adam Freund
Founders
- Narsi RangachariGregory MarcusCarlos SchulerJohn PattonAdam Freund
Company Collections
These are collections InCarda Therapeutics is a part of. Click on the collection name to view similar companies.
InCarda Therapeutics' Investors
InCarda Therapeutics' Industries
InCarda Therapeutics Headquarters Location
Total Amount Raised: $129,376,976
InCarda Therapeutics' Investors
InCarda Therapeutics Funding Rounds
Series A
$43,000,000
Series A
$43,000,000
Series A Investors
Alumni Ventures GroupAndreessen HorowitzBiovision VenturesValhalla VenturesIndicator VenturesRV InvestGVGaingelsEli Lilly and CompanyMana VenturesLifeLink VenturesTwo Sigma VenturesExitfundSeries Unknown
$8,500,000
Series Unknown
$8,500,000
Series C
$30,000,000
Series C
$30,000,000
Series C Investors
TheravanceDeerfield ManagementHealthCapMorningsideSeries B
$42,000,000
Series B
$42,000,000
Series B Investors
HealthCapSofinnova Partners5Y CapitalDeerfield ManagementAsset Management VenturesSeries A
$5,000,000
Series A
$5,000,000
Series A Investors
Morningside Private InvestorsSeed
$566,977
Seed
$566,977
Debt Financing
$310,000
Debt Financing
$310,000
InCarda Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on InCarda Therapeutics.